On the effect of mutations in bovine or camel chymosin on the thermodynamics of binding κ-caseins

Proteins
Samiul M AnsariDavid S Palmer

Abstract

Bovine and camel chymosins are aspartic proteases that are used in dairy food manufacturing. Both enzymes catalyze proteolysis of a milk protein, κ-casein, which helps to initiate milk coagulation. Surprisingly, camel chymosin shows a 70% higher clotting activity than bovine chymosin for bovine milk, while exhibiting only 20% of the unspecific proteolytic activity. By contrast, bovine chymosin is a poor coagulant for camel milk. Although both enzymes are marketed commercially, the disparity in their catalytic activity is not yet well understood at a molecular level, due in part to a lack of atomistic resolution data about the chymosin-κ-casein complexes. Here, we report computational alanine scanning calculations of all four chymosin-κ-casein complexes, allowing us to elucidate the influence that individual residues have on binding thermodynamics. Of the 12 sequence differences in the binding sites of bovine and camel chymosin, eight are shown to be particularly important for understanding differences in the binding thermodynamics (Asp112Glu, Lys221Val, Gln242Arg, Gln278Lys. Glu290Asp, His292Asn, Gln294Glu, and Lys295Leu. Residue in bovine chymosin written first). The relative binding free energies of single-point mutants of ch...Continue Reading

References

Apr 20, 1967·Biochemical and Biophysical Research Communications·I Schechter, A Berger
Aug 20, 1984·FEBS Letters·L Pearl, T Blundell
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·D M YorkT A Darden
Mar 1, 1994·Protein Engineering·J AqvistJ E Samuelsson
Mar 1, 1985·Physical Review A: General Physics·W G Hoover
Mar 27, 2002·Journal of Computational Chemistry·Shuanghong HuoPeter A Kollman
Dec 4, 2003·Journal of Computational Chemistry·Holger Gohlke, David A Case
Mar 20, 2004·Science·William L Jorgensen
Dec 21, 2004·Nucleic Acids Research·Amos BairochLai-Su L Yeh
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Feb 21, 2006·Biochemical and Biophysical Research Communications·Stefan R KappelerEric Johansen
Dec 30, 2006·Journal of Computational Chemistry·Irina S MoreiraMaria J Ramos
Dec 24, 2008·The Journal of Chemical Physics·Stefan M Kast, Thomas Kloss
Aug 7, 2009·Journal of the American Chemical Society·Takashi ImaiAkinori Kidera
May 5, 2010·Journal of Chemical Theory and Computation·Tyler LuchkoAndriy Kovalenko
Jun 8, 2010·The Journal of Physical Chemistry. B·Samuel GenhedenUlf Ryde
Jul 27, 2010·Protein Engineering, Design & Selection : PEDS·Richard T BradshawIan R Gould
Aug 11, 2010·Journal of the American Chemical Society·Riccardo BaronJ Andrew McCammon
Mar 17, 2011·Journal of Physics. Condensed Matter : an Institute of Physics Journal·David S PalmerMaxim V Fedorov
May 2, 2013·Acta Crystallographica. Section D, Biological Crystallography·Jesper Langholm JensenSine Larsen
May 24, 2013·The Journal of Physical Chemistry. B·Andrew D WhiteShaoyi Jiang
Jul 10, 2013·Journal of Agricultural and Food Chemistry·Jesper SørensenBirgit Schiøtt
Mar 10, 2015·The Journal of Chemical Physics·Maksim MisinDavid S Palmer
Jan 11, 2011·Journal of Chemical Theory and Computation·Frank Jensen, David S Palmer
Jan 13, 2016·The Journal of Physical Chemistry. B·Maksim MisinDavid S Palmer
Jun 9, 2016·The Journal of Physical Chemistry. B·Maksim MisinMaxim V Fedorov
Nov 24, 2016·The Journal of Chemical Physics·Maksim MisinDavid S Palmer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.